These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6652932)

  • 1. Longterm pergolide treatment of acromegaly.
    Kendall-Taylor P; Upstill-Goddard G; Cook D
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):711-9. PubMed ID: 6652932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabergoline treatment of acromegaly: a preliminary dose finding study.
    Jackson SN; Fowler J; Howlett TA
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):745-9. PubMed ID: 9274706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
    Franks S; Horrocks PM; Lynch SS; Butt WR; London DR
    Lancet; 1981 Sep; 2(8248):659-61. PubMed ID: 6116045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone.
    Kleinberg DL; Boyd AE; Wardlaw S; Frantz AG; George A; Bryan N; Hilal S; Greising J; Hamilton D; Seltzer T; Sommers CJ
    N Engl J Med; 1983 Sep; 309(12):704-9. PubMed ID: 6888442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabergoline in the treatment of acromegaly: a study in 64 patients.
    Abs R; Verhelst J; Maiter D; Van Acker K; Nobels F; Coolens JL; Mahler C; Beckers A
    J Clin Endocrinol Metab; 1998 Feb; 83(2):374-8. PubMed ID: 9467544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients.
    Ferrari C; Paracchi A; Romano C; Gerevini G; Boghen M; Barreca A; Fortini P; Dubini A
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):467-76. PubMed ID: 2908102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.
    Ho KY; Weissberger AJ; Marbach P; Lazarus L
    Ann Intern Med; 1990 Feb; 112(3):173-81. PubMed ID: 2404445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a new ergoline derivative, CU 32-085, in the treatment of acromegaly. A controlled study.
    Eskildsen PC; Hommel E; Buchhave J
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):189-200. PubMed ID: 3886207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.
    Franks S; Horrocks PM; Lynch SS; Butt WR; London DR
    Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1177-9. PubMed ID: 6404378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pergolide mesylate: its effects on circulating anterior pituitary hormones in man.
    Perryman RL; Rogol AD; Kaiser DL; MacLeod RM; Thorner MO
    J Clin Endocrinol Metab; 1981 Oct; 53(4):772-8. PubMed ID: 6793609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.
    Verde G; Chiodini PG; Liuzzi A; Cozzi R; Favales F; Botalla L; Spelta B; Dalla Bonzana D; Rainer E; Horowski R
    J Endocrinol Invest; 1980; 3(4):405-14. PubMed ID: 6782153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly.
    al-Maskari M; Gebbie J; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):415-21. PubMed ID: 8959079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
    Oppizzi G; Liuzzi A; Chiodini P; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Tonon C
    J Clin Endocrinol Metab; 1984 Jun; 58(6):988-92. PubMed ID: 6725515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with octreotide and bromocriptine in patients with acromegaly: an open pharmacodynamic interaction study.
    Fredstorp L; Kutz K; Werner S
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):103-8. PubMed ID: 8050122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.
    Selvarajah D; Webster J; Ross R; Newell-Price J
    Eur J Endocrinol; 2005 Apr; 152(4):569-74. PubMed ID: 15817912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different dopaminergic agents in the treatment of acromegaly.
    Colao A; Ferone D; Marzullo P; Di Sarno A; Cerbone G; Sarnacchiaro F; Cirillo S; Merola B; Lombardi G
    J Clin Endocrinol Metab; 1997 Feb; 82(2):518-23. PubMed ID: 9024247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.